• BCN Peptides iniciates a collaboration with IDP-Pharma

    April 3, 2017


    BCN Peptides supports IDP-Pharma in the development of a new chemical entity aimed to treat Multiple Myeloma.

    The collaborative project has been granted with funds from the European Union FEDER via ACCIO and its programme”Nuclis d’Innovació Tecnológica”.

     

  • BCN Peptides R&D on Lysosomal Storage Diseases

    March 20, 2017


    BCN Peptides  is working in a research program having as therapeutic target  Lysosomal Storage diseases, a group of  rare inherited metabolic disorders that result from defects in lysosomal function.

    The project, enclosed in “Nuclis d’Innovació Tecnològica” program from ACCIÒ, is cofinanced with the European Union FEDER funds.